Research Article - (2022) Volume 10, Issue 3
Leaves of Plantago lanceolata were traditionally used to treat wounds, burns,
inflammations, fevers, diabetes, and cancer. The present study was carried
out on the Gas Chromatography-Mass Spectrometry (GC-MS) Analysis and
Antitubercular Activities of Leaf Extract of Plantago lanceolata since the plant
was used for wound healing in Ethiopia. The n-hexane extracted powdered
leaves of Plantago lanceolata herb oil were investigated by GC-MS and showed
the presence of 26 compounds. Among these, the major constituents of leaf
oil were 9-Octadecenoic acid (24.20%) and hexadecanoic acid (23.65%).
hence the present work may support the medicinal use of Plantago lanceolata.
The Methyl Isocyanate (MIC) of the crude extracts showed an inhibitory effect
on M. tuberculosis H37Rv was determined at different concentrations of 50
μg/ml, 25 μg/ml, 12.5 μg/ml, 6.25 μg/ml, 3.12 μg/ml, 1.56 μg/ml, and 0.78
μg/ml. Accordingly, the Methyl Isocyanate (MIC) of the pet, the ether extract
was 12.5 μg/ml; while that of CHCl3: MeOH (1:1) and MeOH extract was 6.25
μg/ml and 1.56 μg/ml respectively. It can be concluded that the present study
provided scientific support for the traditional use of Plantago lanceolata leaf
extract for the treatment of tuberculosis.
Analysis • Leaf oil • Antitubercular • Plantago lanceolata
It has been discovered that higher plant extracts are a promising source of anti-TB compounds. Herbal medicine is based on the fact that a single plant may contain thousands of constituents with the possibility of discovering a new drug [1]. Tuberculosis is a highly infectious disease in about one-third of the world’s population. However, this problem has become serious as Mycobacterium tuberculosis developed resistance against both the first line and also the second-line drugs. Due to this, there is the emergence of Multi-Drug Resistant (MDR) and Extensively Drug-Resistant (XDR) strains of M. tuberculosis all over the world including in Ethiopia [2].
Tuberculosis (TB) is one of the oldest diseases known to humanity. It remains one of the major deadliest infectious diseases for humans. The global Tuberculosis (TB) epidemic situation has been further aggravated by the emergence of Human Immunodeficiency Virus (HIV) infection and strains of drug-resistant Tuberculosis (TB). Multidrug-Resistant TB (MDR-TB) has been reported in almost all parts of the world, primarily as a consequence of poor treatment services, which have not only increased the costs of treatment but also increased the risk of transmission of these resistant strains of the bacilli as it stated in [3]. Among the medicinal species of therapeutic interest is included Plantago lanceolata L. which is a species of the genus Plantago in the Plantaginaceae botanical family that originated from Europe, widely spread throughout the world. Plantago lanceolata L. is a common perennial weed of arable fields and grassland abundant throughout Europe, North and Central Asia (Figure 1).
Figure 1: Image of Plantago lanceolata herb taken by Shuma.
Recently, in many countries including Mexico and Argentina, a lot of reports on the use of Plantago species in traditional medicine against cancer have been presented [4]. In Ethiopia, common plantain is a plant known as a weed, but it also has an old traditional medicinal value of wound healing and has got an application for many skin disorders [5-6].
Collection and Identification of the Plant Material
The leaves of Plantago lanceolata L., the herb were collected from Haramaya University’s main campus, Haramaya in December 2016. The botanical specimen of the plant was identified and the voucher specimen was deposited at the Herbarium, Haramaya University as stated in [7].
Collection and Identification of the Plant Material
The leaves of Plantago lanceolata L., the herb were collected from Haramaya University’s main campus, Haramaya in December 2016. The botanical specimen of the plant was identified and the voucher specimen was deposited at the Herbarium, Haramaya University as stated in [7].
Extraction of the Plant Material
The collected leaf was washed repeatedly and dried in an open-air protected from direct exposure to sunlight. Air-dried leaves of Plantago lanceolata L., were grinded by the analytical mill and packed in polyethylene bags. A 210 g of the powdered P. lanceolata L., leaves were then extracted with petroleum ether for 8 h in soxhlet apparatus (60 g of each) and soaked with 300 mL of petroleum ether and heated with heating mantle at 45°C for 8 h, and filtered with filter paper. The filtrate was collected and concentrated at 40°C under reduced pressure using a Rotary evaporator. After air-drying at room temperature, the defatted marc was subjected to a soxhlet extractor with CHCl3: MeOH (1:1) for 8 hours. Then filtered using Whatman No.1 filter paper and concentrated using a Rotary evaporator at 40°C under reduced pressure. The marc collected after CHCl3/MeOH extraction was dried at room temperature for further extraction with Methanol (MeOH) by the same procedure. This procedure was repeated until sufficient crude extract was collected and the crude extract was kept at 4°C until analysis as stated in [7].
Extraction of n-hexane Crude Oil
The dried and powdered leaf of Plantago lanceolata was extracted with n-hexane using a soxhlet apparatus at 60°C for 3 h to obtain the low polar components. During the extraction procedure, 98% n-hexane ACS grade was used as an extracting solvent. The obtained extracts were concentrated by a rotary evaporator under reduced pressure at 40°C.
Methylation of n-hexane Crude Oil
After removing hexane using a rotary evaporator the oily mixtures were derived from their methyl esters according to the general guidelines given by the International Olive Oil Council (IOOC) and the International Union of Pure and Applied Chemistry (IUPAC) described by the transesterification process as reported in [8]. In this process dried n-hexane extracts (1 gm) were dissolved in hexane and then allowed to react with a methanolic solution (5 mL) of KOH (2M) at room temperature for 30 min. The upper phase was subsequently analyzed by means of Gas Chromatography-Mass Spectrometry (GC-MS) systems.
GC-MS Analyses of Plantago lanceolata n-hexane Leaf Extract Crude Oil
The crude oils from the leaf of Plantago lanceolata were analyzed with a Gas Chromatography-Mass Spectrometry (GC-MS) system consisting of an Agilent Technology model 7820A GC using HP-5 Column (30 m length, 0.25 mm internal diameter × 0.25 µm film thickness) which was coated with 5% phenyl 95% methyl polysiloxane as the stationary phase. The syringe was washed with 5 µL of dichloromethane and 1 µL of the esterified sample in dichloromethane was injected through an autosampler and analyzed with the HP-5 Column. The column temperature was programmed as follows: 50% to 120°C at 20°C/min (with 10 min hold time) and 4 min solvent delay. The inlet temperature was fixed to 275°C. The carrier gas was helium with a constant flow of (1.0 mL/min). The interface temperature was 2800°C. The sample was injected in splitless mode. The mass spectra were recorded in electron ionization mode at 70 eV with scanning from 40 m/z to 600 m/z. The ion source temperature was set at 150°C and the quadruple temperature was 230°C. The composition of each constituent in the oil was determined based on GC peak areas. The constituents of the essential oil were identified by their retention time MH\Mass Hunter\Library search\NIST 14.
Testing for Antitubercular Activity
Drug susceptibility and determination of MIC of the test Plantago lanceolata crude extracts against M. tuberculosis H37Rv was performed by agar microdilution method where twofold dilutions of each test compound were added into 7H10 agar supplemented with Oleic Acid-Albumin-Dextrose-Catalase (OADC) and organism. A culture of M. tuberculosis H37Rv growing on L-J medium (Lowenstein-Jensen medium) was harvested in 0.85% saline with 0.05% Tween 80. A suspension of 1 µg/mL concentration of extracts/compounds was prepared in Dimethyl Sulfoxide (DMSO). This suspension was added to (in tubes) 7H10 Middle brook’s medium (containing 1.7 mL medium and 0.2 mL OADC supplement) at different concentrations of extract keeping the volume constant, that is, 0.1 mL. The medium was allowed to cool keeping the tubes in a slanting position. These tubes were then incubated at 37°C for 24 h followed by streaking of M. tuberculosis H37Rv (5 × 104 bacilli per tube). These tubes were then incubated at 37°C. Growth of bacilli was seen after 30 days of incubation. Tubes having the compounds were compared with control tubes where the medium alone was incubated with H37Rv. The concentration at which complete inhibition of colonies occurred was taken as Minimum Inhibitory Concentration (MIC) of test extract [9]. The MIC of the crude extracts showed an inhibitory effect on M. tuberculosis H37Rv was determined at different concentrations of 50 µg/mL, 25 µg/mL, 12.5 µg/mL, 6.25 µg/mL, 3.12 µg/mL, 1.56 µg/mL, and 0.78 µg/mL. Rifampin, Ethambutol, and Isoniazid were used as standard drug against M. tuberculosis.
GC-MS Characterization of Plantago lanceolata n-hexane Extracted Oil
The oil composition was assessed through analysis by combined gas GC-MS. Identification of chemical constituents of the oil was determined by their GC retention index and interpretation of their mass spectra and confirmed by mass spectral library search using the National Institute of Standards and Technology (NIST) as reported by [8]. The gas chromatogram of n-hexane extracted oil of the leaf of the plant showed the presence of 26 compounds and 100.00 % of components of n-hexane extracted oil has been identified in table 2. It was found that the major constituents of n-hexane extracted oil were 9-octadecenoic acid (24.20%), hexadecanoic acid (23.65%), methyl tetradecanoate (6.69%), 2,5-dimethoxy-4-(methylsulfonyl) amphetamine (6.15%), N-(1-cyclohexyl ethyl) benzene ethanamine (5.60%), N-(aminocarbonyl)-2-acetamide (4.73%) and 2-cyano-1-methyl-2-phenoxy ethylamine (4.53%).
Table 1. GC-MS analysis result of Plantago lanceolata n-hexane extracted Oil.
Compound Identified |
Rt |
M.F |
Area (%) |
α-Pinene |
5.37 |
C10H16 |
2.69 |
Bicyclo[3.1.0] hexane |
6.06 |
C6H10 |
1.72 |
β-Pinene |
6.04 |
C10H16 |
2.83 |
2-cyano-1-methyl-2phenoxyethylamine |
6.20 |
C10H12NO |
4.53 |
N-methyl-1-(3,5-dimethyl-1-adamantanoyl)semicarbazide |
6.81 |
C15H25NO2 |
0.64 |
3-methoxyamphetamine |
6.95 |
C10H15NO |
2.05 |
N-(aminocarbonyl)-2-chloro-Acetamide |
7.00 |
C3H5ClN2 |
4.73 |
2-chloro-Benzenemethanol |
7.40 |
C7H7ClO |
0.53 |
dl-Alanylglycylglycine |
12.56 |
C7H13N3O4 |
0.64 |
2-Aminononadecane |
13.636 |
C19H41N |
2.04 |
N-methyl-1-octanamine |
13.953 |
C9H21N |
0.32 |
1-Octanamine |
14.849 |
C8H19N |
0.61 |
5-(2-Aminopropyl)-2-methylphenol |
14.909 |
C10H15NO |
0.55 |
dl-Alanyl-dl-valine |
15.627 |
C8H16N2O3 |
0.37 |
Amphetamine |
15.938 |
C9H13N |
1.94 |
1-Propanamine |
15.995 |
C3H9N |
0.90 |
Methyl tetradecanoate |
16.299 |
C15H30O2 |
6.69 |
R-(-)-Cyclohexylethylamine |
17.163 |
C8H17N |
0.51 |
(2-Aziridinylethyl) amine |
17.524 |
C4H10N2 |
0.85 |
Acetic acid |
17.707 |
CH2CHOH |
0.49 |
N-methyl-2-Formylhistamine |
18.623 |
C7H11N3O |
1.55 |
Hexadecanoic acid |
18.909 |
C16H32O2 |
23.65 |
2-Ethoxyamphetamine |
21.690 |
C11H17NO |
3.24 |
9-octadecenoic acid |
21.798 |
C18H34O2 |
24.20 |
2,5-dimethoxy-4-(methylsulfonyl) amphetamine |
22.018 |
C12H19NO4S |
6.15 |
N-(1-cyclohexylethyl) benzene ethanamine |
22.241 |
C16H25N |
5.60 |
Structures of Major Compounds of Plantago lanceolata n-hexane Extracted Oil
Plantago lanceolata leaf showed the presence of twenty-six compounds using GC-MS (Table 1 and Figure 2). 9-Octadecenoic acid (24.20%) and hexadecanoic acid (23.65%) were the most abundant compounds of the n-hexane extracted oil of the plant leaves.
Figure 2. Structures of the Major Constituents of Plantago lanceolata n-hexane extracted Oil.
Antitubercular Activity of Plantago lanceolata crude extracts
Table 2. Antitubercular activity of Plantago lanceolata crude extracts.
Sample |
Pet. Ether extracts |
CHCl3: MeOH (1:1) extracts |
MeOH extracts |
Rifampicin |
Ethambutol |
Isoniazid |
MIC (µg/ml) |
12.5 |
6.25 |
1.56 |
0.75 |
3.25 |
0.65 |
The MIC of the crude extracts showed an inhibitory effect on M. tuberculosis H37Rv was determined at different concentrations of 50, 25, 12.5, 6.25, 3.12, 1.56, and 0.78 µg/ml. Accordingly, the MIC of pet. The ether extract was 12.5 µg/ml; while that of CHCl3: MeOH (1:1) and MeOH extract was 6.25 and 1.56 µg/ml respectively (table 2). One can observe that the antitubercular effects increased as the polarity of extracted solvents increased. From the previous study high presence of tannins and saponins observed in MeOH extracts may enhance the Antituber activity of MeOH extracts [7]. Hence, the findings indicate that Plantago lanceolata extracts could be used as adjuvant therapy for TB (Figure 3).
Figure 3. GC-MS of Plantago lanceolata n-hexane extracted Oil.
It can be concluded that the present study provided scientific support for the traditional use of Plantago lanceolata leaf extract for the treatment of tuberculosis.
Received: 24-Feb-2022, Manuscript No. NPCR-22-16009; Editor assigned: 05-Mar-2022, Pre QC No. NPCR-22-16009 (PQ); Reviewed: 18-Mar-2022, QC No. NPCR-22-16009; Revised: 21-Mar-2022, Manuscript No. NPCR-22-16009 (R); Published: 10-Apr-2022, DOI: 10.37532/npcr.22.10.3.01-04
Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.